SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Rapezzi C)
 

Sökning: WFRF:(Rapezzi C) > Jaarsma Tiny > Heart failure in ca...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007573naa a2200901 4500
001oai:DiVA.org:liu-158844
003SwePub
008190716s2019 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:141135242
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1588442 URI
0247 a https://doi.org/10.1002/ejhf.14612 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1411352422 URI
040 a (SwePub)liud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Seferovic, Petar M.u Univ Belgrade, Serbia; Serbian Acad Arts and Sci, Serbia,Univ Brescia, Italy4 aut
2451 0a Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
264 c 2019-04-16
264 1b WILEY,c 2019
338 a print2 rdacarrier
520 a Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, and distinct features of their therapeutic responses have not been systematically addressed. Therefore, this position paper focuses on epidemiology, pathophysiology, natural history and latest developments in treatment of HF in patients with dilated (DCM), hypertrophic (HCM) and restrictive (RCM) cardiomyopathies. In DCM, HF with reduced ejection fraction (HFrEF) has high incidence and prevalence and represents the most frequent cause of death, despite improvements in treatment. In addition, advanced HF in DCM is one of the leading indications for heart transplantation. In HCM, HF with preserved ejection (HFpEF) affects most patients with obstructive, and similar to 10% of patients with non-obstructive HCM. A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is common, while HFrEF occurs later and more frequently in amyloidosis or iron overload/haemochromatosis. Irrespective of RCM aetiology, HF is a harbinger of a poor outcome. Recent advances in our understanding of the mechanisms underlying the development of HF in cardiomyopathies have significant implications for therapeutic decision-making. In addition, new aetiology-specific treatment options (e.g. enzyme replacement therapy, transthyretin stabilizers, immunoadsorption, immunotherapy, etc.) have shown a potential to improve outcomes. Still, causative therapies of many cardiomyopathies are lacking, highlighting the need for the development of effective strategies to prevent and treat HF in cardiomyopathies.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a Heart failure; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Restrictive cardiomyopathy; Peripartum cardiomyopathy; Epidemiology; Natural history; Pathophysiology; Management
7001 a Polovina, Marijau Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Bauersachs, Johannu Med Sch Hannover, Germany4 aut
7001 a Arad, Michaelu Tel Aviv Univ, Israel4 aut
7001 a Ben Gal, Tuviau Tel Aviv Univ, Israel4 aut
7001 a Lund, Lars H.u Karolinska Institutet,Karolinska Univ Hosp, Sweden4 aut
7001 a Felix, Stephan B.u Univ Med Greifswald, Germany4 aut
7001 a Arbustini, Eloisau Univ Hosp Policlin San Matteo, Italy4 aut
7001 a Caforio, Alida L. P.u Univ Padua, Italy4 aut
7001 a Farmakis, Dimitriosu Univ Cyprus, Cyprus; Univ Athens, Greece4 aut
7001 a Filippatos, Gerasimos S.u Univ Cyprus, Cyprus; Univ Athens, Greece4 aut
7001 a Gialafos, Eliasu Henry Dunant Hosp, Greece4 aut
7001 a Kanjuh, Vladimiru Serbian Acad Arts and Sci, Serbia4 aut
7001 a Krljanac, Gordanau Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Limongelli, Giuseppeu Univ Campania Luigi Vanvitelll, Italy; UCL Inst Cardiovasc Sci, England4 aut
7001 a Linhart, Alesu Charles Univ Prague, Czech Republic4 aut
7001 a Lyon, Alexander R.u Imperial Coll London, England; Royal Brompton Hosp, England4 aut
7001 a Maksimovic, Ruzicau Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Milicic, Davoru Univ Zagreb, Croatia4 aut
7001 a Milinkovic, Ivanu Clin Ctr Serbia, Serbia4 aut
7001 a Noutsias, Michelu Martin Luther Univ Halle Wittenberg, Germany4 aut
7001 a Oto, Aliu Hacettepe Univ, Turkey4 aut
7001 a Oto, Oztekinu Dokuz Eylul Univ, Turkey4 aut
7001 a Pavlovic, Sinisa U.u Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Piepoli, Massimo F.u Guglielmo da Saliceto Hosp, Italy4 aut
7001 a Ristic, Arsen D.u Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Rosano, Giuseppe M. C.u IRCCS San Raffaele, Italy; Univ London, England,Univ Basel, Switzerland; Univ Basel, Switzerland4 aut
7001 a Seggewiss, Hubertu Klinikum Wurzburg Mitte, Germany4 aut
7001 a Asanin, Milikau Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia4 aut
7001 a Seferovic, Jelena R.u Univ Belgrade, Serbia; Harvard Med Sch, MA 02115 USA; Univ Belgrade, Serbia4 aut
7001 a Ruschitzka, Franku Univ Heart Ctr, Switzerland4 aut
7001 a Celutkiene, Jelenau Vilnius Univ, Lithuania; State Res Inst Ctr Innovat Med, Lithuania4 aut
7001 a Jaarsma, Tinyu Linköpings universitet,Avdelningen för omvårdnad,Medicinska fakulteten4 aut0 (Swepub:liu)tinja77
7001 a Mueller, Christianu Univ Basel, Switzerland; Univ Basel, Switzerland4 aut
7001 a Moura, Brendau Ctr Hosp Sao Joao, Portugal4 aut
7001 a Hill, Loreenau Queens Univ Belfast, North Ireland4 aut
7001 a Volterrani, Mauriziou IRCCS San Raffaele Pisana, Italy4 aut
7001 a Lopatin, Yuriu Volgograd State Med Univ, Russia4 aut
7001 a Metra, Marcou Univ Brescia, Italy4 aut
7001 a Backs, Johannesu Heidelberg Univ, Germany; DZHK German Ctr Cardiovasc Res, Germany4 aut
7001 a Mullens, Wilfriedu Hasselt Univ, Belgium; Ziekenhuis Oost Limburg, Belgium4 aut
7001 a Chioncel, Ovidiuu Univ Med and Pharm Carol Davila, Romania; Emergency Inst Cardiovasc Dis Prof CC Iliescu, Romania4 aut
7001 a de Boer, Rudolf A.u Univ Groningen, Netherlands4 aut
7001 a Anker, Stefanu Dept Cardiol CVK, Germany; Berlin Brandenburg Ctr Regenerat Therapies BCRT, Germany; DZHK German Ctr Cardiovasc Res, Germany4 aut
7001 a Rapezzi, Claudiou Alma Mater Studiorum Univ Bologna, Italy4 aut
7001 a Coats, Andrew J. su Monash Univ, Australia; Univ Warwick, England; IRCCS San Raffaele Pisana, Italy; St Georges Univ London, England4 aut
7001 a Tschoepes, Carstenu Charite Univ Med Berlin, Germany4 aut
7102 a Univ Belgrade, Serbia; Serbian Acad Arts and Sci, Serbiab Univ Brescia, Italy4 org
7730 t European Journal of Heart Failured : WILEYg 21:5, s. 553-576q 21:5<553-576x 1388-9842x 1879-0844
8564 u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.1461
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-158844
8564 8u https://doi.org/10.1002/ejhf.1461
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141135242

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy